{"id":745588,"date":"2017-02-16T08:00:00","date_gmt":"2017-02-16T08:00:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/"},"modified":"2025-11-07T01:26:39","modified_gmt":"2025-11-07T06:26:39","slug":"mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/","title":{"rendered":"Merck\u2019s Fight Against Infectious Disease Goes Digital with Launch of IL\u00daM Health Solutions"},"content":{"rendered":"<p>\n      Merck (NYSE:MRK), known as MSD outside the United States and Canada,<br \/>\n      today announced the launch of IL\u00daM Health Solutions, which provides<br \/>\n      enterprise-wide disease management tools and services to enable improved<br \/>\n      outcomes for patients with infectious diseases, such as sepsis and<br \/>\n      pneumonia, while supporting antimicrobial stewardship initiatives. IL\u00daM<br \/>\n      operates independently from Merck\u2019s pharmaceutical and vaccine products<br \/>\n      businesses as part of Merck\u2019s Healthcare Services &amp; Solutions (HSS)<br \/>\n      group.\n    <\/p>\n<p>\n      \u201cWe are pleased to offer IL\u00daM in the United States as a way to<br \/>\n      strategically partner with health systems to fight infectious diseases<br \/>\n      and combat the threat of antimicrobial resistance,\u201d said Guy Eiferman,<br \/>\n      managing director, HSS. \u201cIt is an important step for our Healthcare<br \/>\n      Services and Solutions business, and complements Merck\u2019s company-wide<br \/>\n      efforts to develop and deliver innovative approaches to address some of<br \/>\n      today\u2019s most pressing health issues.\u201d\n    <\/p>\n<p>\n      IL\u00daM Insight\u2122 \u2013 ID leverages data within existing hospital IT systems to<br \/>\n      promote optimal decision making and appropriate use of antimicrobials<br \/>\n      through its clinical decision support (CDS) system and Command Center<br \/>\n      (an intuitive data dashboard). These solutions enable case monitoring<br \/>\n      and prioritization\u2014on an individual and aggregate level based on disease<br \/>\n      state\u2014and promote early recognition of infectious diseases, appropriate<br \/>\n      interventions, and adherence to evidence-based clinical pathways. They<br \/>\n      also provide automated outcomes reporting that is configured to<br \/>\n      hospital-specific initiatives to track quality program performance.\n    <\/p>\n<p>\n      In 2015, IL\u00daM initiated a collaboration with East Jefferson General<br \/>\n      Hospital (EJGH), a 424-bed general medical and surgical hospital in<br \/>\n      Metairie, La., to pilot IL\u00daM\u2019s CDS system with an initial focus on<br \/>\n      improving the impact of the hospital\u2019s quality program for sepsis care<br \/>\n      improvement. Sepsis is a potentially life-threatening complication of an<br \/>\n      infection, resulting in 750,000 deaths in the United States and more<br \/>\n      than $20 billion in aggregate costs annually, with studies demonstrating<br \/>\n      that hospitals spend approximately $34,000 caring for each patient with<br \/>\n      severe sepsis.\n    <\/p>\n<p>\n      \u201cEast Jefferson General Hospital has a strong commitment to the early<br \/>\n      recognition and management of sepsis, which are critical to survival,\u201d<br \/>\n      said Raymond DeCorte, chief medical officer, EJGH. \u201cWe are partnering<br \/>\n      with IL\u00daM as part of an ongoing, hospital-wide initiative targeting<br \/>\n      sepsis quality improvement, which includes multi-disciplinary<br \/>\n      departmental collaborations and sponsorship from administration and<br \/>\n      medical leadership. This innovative solution has helped us to identify<br \/>\n      patients with sepsis faster, care for them better and reduce the use of<br \/>\n      critical hospital resources. We look forward to continuing to work with<br \/>\n      IL\u00daM to fight infection and support our antimicrobial stewardship<br \/>\n      initiatives.\u201d\n    <\/p>\n<p>\n      Preliminary results from the EJGH pilot were presented at the Institute<br \/>\n      for Healthcare Improvement\u2019s 28th Annual National Forum on Quality<br \/>\n      Improvement in Health Care in December 2016. Data showed that with<br \/>\n      IL\u00daM\u2019s CDS system, clinicians at EJGH improved their identification of<br \/>\n      patients with severe sepsis and achieved high adherence rates to the<br \/>\n      hospital\u2019s guideline-based sepsis care pathway. Comparing data from<br \/>\n      twelve months prior (control group, May 2014 to April 2015) to twelve<br \/>\n      months after (study group, September 2015 to August 2016) the IL\u00daM CDS<br \/>\n      implementation, there was significant improvement in clinical outcomes<br \/>\n      and reduction in utilization of healthcare resources. Among patients<br \/>\n      with all sepsis types, a reduction in hospital length-of-stay (7.11 to<br \/>\n      6.81 days; p=0.05) was observed. Among patients with severe sepsis,<br \/>\n      significantly fewer patients developed hospital-onset shock in the study<br \/>\n      group compared to the control group (19 percent vs. 35 percent; p=0.006).\n    <\/p>\n<p>\n      \u201cThe IL\u00daM team is focused on helping hospitals improve quality and<br \/>\n      optimize care by working with doctors, nurses, quality managers,<br \/>\n      pharmacists and hospital leadership every step of the way,\u201d said Dr.<br \/>\n      Brandon Palermo, executive director and chief medical officer, HSS. \u201cWe<br \/>\n      are pleased with the results achieved to date at EJGH, and look forward<br \/>\n      to presenting additional results, including mortality data, at future<br \/>\n      healthcare conferences.\u201d\n    <\/p>\n<p>\n      <b>About IL\u00daM Health Solutions<\/b>\n    <\/p>\n<p>\n      IL\u00daM Health Solutions is part of Merck\u2019s <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.healthcareservicesandsolutions.com%2F&amp;esheet=51511245&amp;newsitemid=20170216005351&amp;lan=en-US&amp;anchor=Healthcare+Services+%26+Solutions&amp;index=1&amp;md5=9845b4df9445304f8fa702a9beeacae1\" rel=\"nofollow\">Healthcare<br \/>\n      Services &amp; Solutions<\/a> (HSS) group, an independent business unit<br \/>\n      focused on improving the value of care delivered to patients through<br \/>\n      evidence-based services and solutions. IL\u00daM Health Solutions is<br \/>\n      organized and managed independently from Merck\u2019s pharmaceutical products<br \/>\n      business. For more information about IL\u00daM Health Solutions, visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ilumhealthsolutions.com%2F%3Futm_campaign%3DILUM_MerckPr_releaseLink%26utm_medium%3DPressRelease%26utm_source%3DMerck%2520PR&amp;esheet=51511245&amp;newsitemid=20170216005351&amp;lan=en-US&amp;anchor=www.IL%C3%9AMhealthsolutions.com&amp;index=2&amp;md5=dd1985c8d7602c086533070e2da1fe3a\" rel=\"nofollow\">www.IL\u00daMhealthsolutions.com<\/a>.\n    <\/p>\n<p>\n      <b>About Merck<\/b>\n    <\/p>\n<p>\n      For over a century, Merck has been a global health care leader working<br \/>\n      to help the world be well. Merck is known as MSD outside the United<br \/>\n      States and Canada. Through our prescription medicines, vaccines,<br \/>\n      biologic therapies, and animal health products, we work with customers<br \/>\n      and operate in more than 140 countries to deliver innovative health<br \/>\n      solutions. We also demonstrate our commitment to increasing access to<br \/>\n      health care through far-reaching policies, programs and partnerships.<br \/>\n      For more information, visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fvip2-msd.com\/merckcom-migrated&amp;esheet=51511245&amp;newsitemid=20170216005351&amp;lan=en-US&amp;anchor=vip2-msd.com\/merckcom-migrated&amp;index=3&amp;md5=ac0e5b272775c0ea9ac1e05e984a4895\" rel=\"nofollow\">vip2-msd.com\/merckcom-migrated<\/a><br \/>\n      and connect with us on <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FMerck&amp;esheet=51511245&amp;newsitemid=20170216005351&amp;lan=en-US&amp;anchor=Twitter&amp;index=4&amp;md5=9076b79fb175933450522f0abc151e55\" rel=\"nofollow\">Twitter<\/a>,<br \/>\n      <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.facebook.com%2FMerckBeWell&amp;esheet=51511245&amp;newsitemid=20170216005351&amp;lan=en-US&amp;anchor=Facebook&amp;index=5&amp;md5=95e47ab5a58eb83c0d7148460a295154\" rel=\"nofollow\">Facebook<\/a>,<br \/>\n      <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.youtube.com%2FMerck&amp;esheet=51511245&amp;newsitemid=20170216005351&amp;lan=en-US&amp;anchor=YouTube&amp;index=6&amp;md5=c625c90284793dba0316c35e5e18bc08\" rel=\"nofollow\">YouTube<\/a><br \/>\n      and <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fmerck&amp;esheet=51511245&amp;newsitemid=20170216005351&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=7&amp;md5=312be3a101b15bdb50c892be9d5cac4f\" rel=\"nofollow\">LinkedIn<\/a>.\n    <\/p>\n<p>\n      <b>Forward-Looking Statement of Merck &amp; Co., Inc., Kenilworth, N.J., USA<\/b>\n    <\/p>\n<p>\n      This news release of Merck &amp; Co., Inc., Kenilworth, N.J., USA (the<br \/>\n      \u201ccompany\u201d) includes \u201cforward-looking statements\u201d within the meaning of<br \/>\n      the safe harbor provisions of the U.S. Private Securities Litigation<br \/>\n      Reform Act of 1995. These statements are based upon the current beliefs<br \/>\n      and expectations of the company\u2019s management and are subject to<br \/>\n      significant risks and uncertainties. If underlying assumptions prove<br \/>\n      inaccurate or risks or uncertainties materialize, actual results may<br \/>\n      differ materially from those set forth in the forward-looking statements.\n    <\/p>\n<p>\n      Risks and uncertainties include but are not limited to, general industry<br \/>\n      conditions and competition; general economic factors, including interest<br \/>\n      rate and currency exchange rate fluctuations; the impact of<br \/>\n      pharmaceutical industry regulation and health care legislation in the<br \/>\n      United States and internationally; global trends toward health care cost<br \/>\n      containment; technological advances, new products and patents attained<br \/>\n      by competitors; challenges inherent in new product development,<br \/>\n      including obtaining regulatory approval; the company\u2019s ability to<br \/>\n      accurately predict future market conditions; manufacturing difficulties<br \/>\n      or delays; financial instability of international economies and<br \/>\n      sovereign risk; dependence on the effectiveness of the company\u2019s patents<br \/>\n      and other protections for innovative products; and the exposure to<br \/>\n      litigation, including patent litigation, and\/or regulatory actions.\n    <\/p>\n<p>\n      The company undertakes no obligation to publicly update any<br \/>\n      forward-looking statement, whether as a result of new information,<br \/>\n      future events or otherwise. Additional factors that could cause results<br \/>\n      to differ materially from those described in the forward-looking<br \/>\n      statements can be found in the company\u2019s 2015 Annual Report on Form 10-K<br \/>\n      and the company\u2019s other filings with the Securities and Exchange<br \/>\n      Commission (SEC) available at the SEC\u2019s Internet site (<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=51511245&amp;newsitemid=20170216005351&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=8&amp;md5=f7fe3ba9808348b18b177ac54c0ecdd0\" rel=\"nofollow\">www.sec.gov<\/a>).\n    <\/p>\n<p class=\"bwalignc\">\n<p>\n<img decoding=\"async\" alt=\"\" src=\"\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20170216005351r1&amp;sid=hq1sc1&amp;distro=nx&amp;lang=en\" \/><br \/>\n<span class=\"bwct31415\" \/><br \/>\n<\/span><\/p>\n<p>       Media:<br \/>Patrick Witmer, 267-305-4910<br \/>or<br \/>Investors:<br \/>Amy        Klug, 908-740-1898     <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the launch of IL\u00daM Health Solutions, which provides enterprise-wide disease management tools and services to enable improved outcomes for patients with infectious diseases, such as sepsis and pneumonia, while supporting antimicrobial stewardship initiatives. IL\u00daM operates independently from Merck\u2019s pharmaceutical and vaccine products businesses as part of Merck\u2019s Healthcare Services &amp; Solutions (HSS) group. \u201cWe are pleased to offer IL\u00daM in the United States as a way to strategically partner with health systems to fight infectious diseases and combat the threat of antimicrobial resistance,\u201d said Guy Eiferman, managing director, HSS. \u201cIt is an important step for our Healthcare Services and Solutions business, and complements Merck\u2019s company-wide efforts to develop and deliver innovative approaches to address some of today\u2019s most pressing health issues.\u201d IL\u00daM Insight\u2122 \u2013 ID leverages data within existing<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[53,64,289],"class_list":["post-745588","news_item","type-news_item","status-publish","hentry","tag-corporate-news","tag-latest-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck\u2019s Fight Against Infectious Disease Goes Digital with Launch of IL\u00daM Health Solutions - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck\u2019s Fight Against Infectious Disease Goes Digital with Launch of IL\u00daM Health Solutions - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the launch of IL\u00daM Health Solutions, which provides enterprise-wide disease management tools and services to enable improved outcomes for patients with infectious diseases, such as sepsis and pneumonia, while supporting antimicrobial stewardship initiatives. IL\u00daM operates independently from Merck\u2019s pharmaceutical and vaccine products businesses as part of Merck\u2019s Healthcare Services &amp; Solutions (HSS) group. \u201cWe are pleased to offer IL\u00daM in the United States as a way to strategically partner with health systems to fight infectious diseases and combat the threat of antimicrobial resistance,\u201d said Guy Eiferman, managing director, HSS. \u201cIt is an important step for our Healthcare Services and Solutions business, and complements Merck\u2019s company-wide efforts to develop and deliver innovative approaches to address some of today\u2019s most pressing health issues.\u201d IL\u00daM Insight\u2122 \u2013 ID leverages data within existing\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-07T06:26:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png\" \/>\n\t<meta property=\"og:image:width\" content=\"3056\" \/>\n\t<meta property=\"og:image:height\" content=\"1380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\\\/\",\"name\":\"Merck\u2019s Fight Against Infectious Disease Goes Digital with Launch of IL\u00daM Health Solutions - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"datePublished\":\"2017-02-16T08:00:00+00:00\",\"dateModified\":\"2025-11-07T06:26:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck\u2019s Fight Against Infectious Disease Goes Digital with Launch of IL\u00daM Health Solutions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck\u2019s Fight Against Infectious Disease Goes Digital with Launch of IL\u00daM Health Solutions - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/","og_locale":"en_US","og_type":"article","og_title":"Merck\u2019s Fight Against Infectious Disease Goes Digital with Launch of IL\u00daM Health Solutions - Merck.com","og_description":"Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the launch of IL\u00daM Health Solutions, which provides enterprise-wide disease management tools and services to enable improved outcomes for patients with infectious diseases, such as sepsis and pneumonia, while supporting antimicrobial stewardship initiatives. IL\u00daM operates independently from Merck\u2019s pharmaceutical and vaccine products businesses as part of Merck\u2019s Healthcare Services &amp; Solutions (HSS) group. \u201cWe are pleased to offer IL\u00daM in the United States as a way to strategically partner with health systems to fight infectious diseases and combat the threat of antimicrobial resistance,\u201d said Guy Eiferman, managing director, HSS. \u201cIt is an important step for our Healthcare Services and Solutions business, and complements Merck\u2019s company-wide efforts to develop and deliver innovative approaches to address some of today\u2019s most pressing health issues.\u201d IL\u00daM Insight\u2122 \u2013 ID leverages data within existing","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/","og_site_name":"Merck.com","article_modified_time":"2025-11-07T06:26:39+00:00","og_image":[{"width":3056,"height":1380,"url":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/","name":"Merck\u2019s Fight Against Infectious Disease Goes Digital with Launch of IL\u00daM Health Solutions - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"datePublished":"2017-02-16T08:00:00+00:00","dateModified":"2025-11-07T06:26:39+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck\u2019s Fight Against Infectious Disease Goes Digital with Launch of IL\u00daM Health Solutions"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"4706f678-dac9-41c4-83e4-711526fc62d2","news_item_aria_label":"","media_files":[{"path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_events\/2017\/02\/1\/merck_logo.jpg","size":"21167","File Upload":""},{"path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_events\/2017\/02\/1\/ILUM_logo.jpg","size":"8305","File Upload":""}],"document_path":"","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":1,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745588\/revisions"}],"predecessor-version":[{"id":3674957,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745588\/revisions\/3674957"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=745588"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=745588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}